# Minerva First No-Mutation Intake Execution Phase Status v0.1

## Phase Summary

The first no-mutation intake execution phase is complete at controlled-readiness/no-mutation level only.

## What Is Now Complete

The execution service, evidence envelope service, execution review service, verification pack service, closeout service, closeout ledger, phase status, and next decision point documents are prepared as deterministic local artefacts.

## What Is Still Deferred

Durable evidence ingestion, corpus mutation, Code Evidence ingestion, DB access/write, live retrieval, live LLM use, final answer generation, chat exposure, endpoint exposure, route registration, runtime integration, deployment readiness, runtime readiness, and production readiness remain deferred.

## Execution Model Prepared

The first no-mutation intake execution service models an in-memory execution against reviewed candidate metadata and keeps all mutation and runtime actions false.

## Evidence Envelope Prepared

The evidence envelope service models review-only evidence metadata and keeps durable ingestion, corpus mutation, Code Evidence ingestion, DB write, live retrieval, live LLM, and final answer generation unauthorised.

## Review Model Prepared

The execution review service verifies execution and envelope metadata and blocks mutation, ingestion, DB, live retrieval, live LLM, final answer, exposure, runtime, deployment, or production claims.

## Verification Pack Prepared

The verification pack service records closeout readiness for the review path while keeping durable-ingestion readiness false.

## Risks / Unknowns

The next phase has not been selected. Durable ingestion design, evidence cataloguing, Code Evidence readiness, and runtime integration each still require explicit future authorisation.

## Quality Guardrails

The closeout remains deterministic, local, in-memory, and test-covered. It does not add an API route, UI, DB access, retrieval backend change, LLM call, migration, corpus mutation, durable ingestion, Code Evidence ingestion, workforce-platform change, or ezeas-analytics change.

## Developer Handoff

Treat this phase as closed only for planning and controlled-readiness evidence. Choose the next phase before making any ingestion, mutation, runtime, exposure, deployment, or production changes.
